An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

Benjamin R. Underwood, Zeyn W. Green-Thompson, Peter J. Pugh, Stanley E. Lazic, Sarah L. Mason, Jules Griffin, P. Simon Jones, James B. Rowe, David C. Rubinsztein, Roger A. Barker

ABSTRACT

Preclinical data have shown that rilmenidine can regulate autophagy in models of Huntington's disease (HD), providing a potential route to alter the disease course in patients. Consequently, a 2-year open-label study examining the tolerability and feasibility of rilmenidine in mild-moderate HD was undertaken. 18 non-demented patients with mild to moderate HD took daily doses of 1 mg Rilmenidine for 6 months and 2 mg for a further 18 months followed by a 3-month washout period. The primary outcome was the number of withdrawals and serious adverse events. Secondary outcomes included safety parameters and changes in disease-specific variables, such as motor, cognitive and functional performance, structural MRI and serum metabolomic analysis. 12 patients completed the study; reasons for withdrawal included problems tolerating study procedures (MRI, and venepuncture), depression requiring hospital admission and logistical reasons. Three serious adverse events were recorded, including hospitalisation for depression, but none were thought to be drug-related. Changes in secondary outcomes were analysed as the annual rate of change in the study group. The overall change was comparable to changes seen in recent large observational studies in HD patients, though direct statistical comparisons to these studies were not made. Chronic oral administration of rilmenidine is feasible and well-tolerated and future, larger, placebo-controlled, studies in HD are warranted. TRIAL REGISTRATION: EudraCT number 2009-018119-14. More... »

PAGES

2457-2463

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00415-017-8647-0

DOI

http://dx.doi.org/10.1007/s00415-017-8647-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1092407062

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29075837


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic alpha-Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Huntington Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Longitudinal Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolomics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuropsychological Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rilmenidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Fulbourn Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415163.4", 
          "name": [
            "Fulbourn Hospital, Fulbourn, CB21 5EF, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Underwood", 
        "givenName": "Benjamin R.", 
        "id": "sg:person.01012741005.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012741005.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Addenbrooke's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.120073.7", 
          "name": [
            "Addenbrooke\u2019s Hospital, Hills Road, CB21 2QQ, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Green-Thompson", 
        "givenName": "Zeyn W.", 
        "id": "sg:person.01244365253.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244365253.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Addenbrooke's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.120073.7", 
          "name": [
            "Addenbrooke\u2019s Hospital, Hills Road, CB21 2QQ, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pugh", 
        "givenName": "Peter J.", 
        "id": "sg:person.0703455320.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703455320.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United Kingdom)", 
          "id": "https://www.grid.ac/institutes/grid.417815.e", 
          "name": [
            "Quantitative Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca, CB4 0WG, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lazic", 
        "givenName": "Stanley E.", 
        "id": "sg:person.01143475656.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143475656.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cambridge", 
          "id": "https://www.grid.ac/institutes/grid.5335.0", 
          "name": [
            "UK Dementia Research Institute, University of Cambridge, Hills Road, CB2 0XY, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mason", 
        "givenName": "Sarah L.", 
        "id": "sg:person.01256130314.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256130314.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cambridge", 
          "id": "https://www.grid.ac/institutes/grid.5335.0", 
          "name": [
            "Department of Biochemistry, University of Cambridge, CB2 1GA, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Griffin", 
        "givenName": "Jules", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cambridge", 
          "id": "https://www.grid.ac/institutes/grid.5335.0", 
          "name": [
            "Department of Clinical Neurosciences, and MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge Biomedical Campus, CB2 0SZ, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jones", 
        "givenName": "P. Simon", 
        "id": "sg:person.015072667762.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015072667762.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cambridge", 
          "id": "https://www.grid.ac/institutes/grid.5335.0", 
          "name": [
            "Department of Clinical Neurosciences, and MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge Biomedical Campus, CB2 0SZ, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rowe", 
        "givenName": "James B.", 
        "id": "sg:person.013473241432.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013473241432.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cambridge", 
          "id": "https://www.grid.ac/institutes/grid.5335.0", 
          "name": [
            "Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Hills Road, CB2 0XY, Cambridge, UK", 
            "UK Dementia Research Institute, University of Cambridge, Hills Road, CB2 0XY, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rubinsztein", 
        "givenName": "David C.", 
        "id": "sg:person.01364457173.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364457173.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cambridge", 
          "id": "https://www.grid.ac/institutes/grid.5335.0", 
          "name": [
            "Addenbrooke\u2019s Hospital, Hills Road, CB21 2QQ, Cambridge, UK", 
            "Department of Clinical Neurosciences, and MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge Biomedical Campus, CB2 0SZ, Cambridge, UK", 
            "John Van Geest Centre for Brain Repair, Forvie Site, Robinson Way, CB2 0PY, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barker", 
        "givenName": "Roger A.", 
        "id": "sg:person.01104460675.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104460675.05"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ng0893-398", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001162353", 
          "https://doi.org/10.1038/ng0893-398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/hmg/ddq093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002040437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/hmg/ddq093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002040437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.mam.2006.08.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005417342"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0895-4356(94)90122-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012537768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000106735", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015122589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/hmg/ddi458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016587798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(10)70276-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020920913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0029522", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022528286"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/brain/awl027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027277788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaneurol.2013.4408", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029048086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaneurol.2013.123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030048782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14656566.2016.1109630", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038137101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.r109.072181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038402062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(11)70263-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041510619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(13)70088-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046613225"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182020123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182020123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182020123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.29.1.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064362593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.54.2.452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064378293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.54.2.452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064378293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.54.2.452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064378293"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "Preclinical data have shown that rilmenidine can regulate autophagy in models of Huntington's disease (HD), providing a potential route to alter the disease course in patients. Consequently, a 2-year open-label study examining the tolerability and feasibility of rilmenidine in mild-moderate HD was undertaken. 18 non-demented patients with mild to moderate HD took daily doses of 1\u00a0mg Rilmenidine for 6\u00a0months and 2\u00a0mg for a further 18\u00a0months followed by a 3-month washout period. The primary outcome was the number of withdrawals and serious adverse events. Secondary outcomes included safety parameters and changes in disease-specific variables, such as motor, cognitive and functional performance, structural MRI and serum metabolomic analysis. 12 patients completed the study; reasons for withdrawal included problems tolerating study procedures (MRI, and venepuncture), depression requiring hospital admission and logistical reasons. Three serious adverse events were recorded, including hospitalisation for depression, but none were thought to be drug-related. Changes in secondary outcomes were analysed as the annual rate of change in the study group. The overall change was comparable to changes seen in recent large observational studies in HD patients, though direct statistical comparisons to these studies were not made. Chronic oral administration of rilmenidine is feasible and well-tolerated and future, larger, placebo-controlled, studies in HD are warranted.\nTRIAL REGISTRATION: EudraCT number 2009-018119-14.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00415-017-8647-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2767200", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3639485", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6446046", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2770378", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2785012", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.4579569", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3864363", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7444390", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1014525", 
        "issn": [
          "0340-5354", 
          "1432-1459"
        ], 
        "name": "Journal of Neurology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "264"
      }
    ], 
    "name": "An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington\u2019s disease", 
    "pagination": "2457-2463", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a2dbcb4d24b622dcc693c9c546282df3afe57828e31f8ce393780f3a4f8f2e3a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29075837"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0423161"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00415-017-8647-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1092407062"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00415-017-8647-0", 
      "https://app.dimensions.ai/details/publication/pub.1092407062"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78953_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00415-017-8647-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00415-017-8647-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00415-017-8647-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00415-017-8647-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00415-017-8647-0'


 

This table displays all metadata directly associated to this object as RDF triples.

296 TRIPLES      21 PREDICATES      67 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00415-017-8647-0 schema:about N078e205de1a8491ab42b8ed905237678
2 N0d93adae07de4d02ac8d88ae8f34d42d
3 N0fe17c3f02cd485fac3c43a0a9989651
4 N2a3f20dcbe1d43a8bb1649a148db84aa
5 N30fdade413324a869b07815d1f2562c2
6 N3be5373611fb43889f1bcdf6f5c22c10
7 N3d54617f7d6c4040869eb59b4b60f14b
8 N4b33503c47d04aec8fe45758083fe38c
9 N521baf8edd204e9a8cc910423c4d8528
10 N5d3c8845ef964ae988ef4ed65157119d
11 N60cc633d94a841c88e68760e302db458
12 N746fdca0896246cc9ee503c912c5f408
13 N94c533a479674b43b194a0c3c8b513ed
14 N9f780e65f00246f285db8aa61642091b
15 Na1262cecbd84433fba2a72ec849eee2f
16 Nd2534afd58824cc68fd1c63e0daf95b8
17 Nd67644bbdf1b4f23b99994e2c3d372e1
18 Ndf7fc0bc95974ca3b1acdd68860827bb
19 Ne1dc296fe12741d68cb9616b61aa491d
20 Nf1aa928140f14cf3b9e30d0af136f1f8
21 anzsrc-for:11
22 anzsrc-for:1117
23 schema:author N3f51ffd08a6b4927930e8381b1a18553
24 schema:citation sg:pub.10.1038/ng0893-398
25 https://doi.org/10.1001/jamaneurol.2013.123
26 https://doi.org/10.1001/jamaneurol.2013.4408
27 https://doi.org/10.1016/0895-4356(94)90122-8
28 https://doi.org/10.1016/j.mam.2006.08.008
29 https://doi.org/10.1016/s1474-4422(10)70276-3
30 https://doi.org/10.1016/s1474-4422(11)70263-0
31 https://doi.org/10.1016/s1474-4422(13)70088-7
32 https://doi.org/10.1074/jbc.r109.072181
33 https://doi.org/10.1093/brain/awl027
34 https://doi.org/10.1093/hmg/ddi458
35 https://doi.org/10.1093/hmg/ddq093
36 https://doi.org/10.1159/000106735
37 https://doi.org/10.1212/wnl.0b013e3182020123
38 https://doi.org/10.1212/wnl.29.1.1
39 https://doi.org/10.1212/wnl.54.2.452
40 https://doi.org/10.1371/journal.pone.0029522
41 https://doi.org/10.1517/14656566.2016.1109630
42 schema:datePublished 2017-12
43 schema:datePublishedReg 2017-12-01
44 schema:description Preclinical data have shown that rilmenidine can regulate autophagy in models of Huntington's disease (HD), providing a potential route to alter the disease course in patients. Consequently, a 2-year open-label study examining the tolerability and feasibility of rilmenidine in mild-moderate HD was undertaken. 18 non-demented patients with mild to moderate HD took daily doses of 1 mg Rilmenidine for 6 months and 2 mg for a further 18 months followed by a 3-month washout period. The primary outcome was the number of withdrawals and serious adverse events. Secondary outcomes included safety parameters and changes in disease-specific variables, such as motor, cognitive and functional performance, structural MRI and serum metabolomic analysis. 12 patients completed the study; reasons for withdrawal included problems tolerating study procedures (MRI, and venepuncture), depression requiring hospital admission and logistical reasons. Three serious adverse events were recorded, including hospitalisation for depression, but none were thought to be drug-related. Changes in secondary outcomes were analysed as the annual rate of change in the study group. The overall change was comparable to changes seen in recent large observational studies in HD patients, though direct statistical comparisons to these studies were not made. Chronic oral administration of rilmenidine is feasible and well-tolerated and future, larger, placebo-controlled, studies in HD are warranted. TRIAL REGISTRATION: EudraCT number 2009-018119-14.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree true
48 schema:isPartOf Ne42a84157f7c45608fd73a4357d338c1
49 Necbb611825194f9b9d6c5b3229117358
50 sg:journal.1014525
51 schema:name An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease
52 schema:pagination 2457-2463
53 schema:productId N3bca04edc4444ed596f5b9eefdbc87be
54 N9bb1b520c52b4d0b80c63ec5df543134
55 Ne109726208634d058327b0bdf06d271d
56 Ne4dc59ffecaf4752af5b23bfb22f595d
57 Nfd2447810cea4ac1bca64111667b3bfc
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092407062
59 https://doi.org/10.1007/s00415-017-8647-0
60 schema:sdDatePublished 2019-04-11T13:19
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher Nf2e7e06300ea43998f10e2b5f5dc5669
63 schema:url https://link.springer.com/10.1007%2Fs00415-017-8647-0
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N078e205de1a8491ab42b8ed905237678 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Aged
69 rdf:type schema:DefinedTerm
70 N0d93adae07de4d02ac8d88ae8f34d42d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Adult
72 rdf:type schema:DefinedTerm
73 N0fe17c3f02cd485fac3c43a0a9989651 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Treatment Outcome
75 rdf:type schema:DefinedTerm
76 N1a979c872b5c4bb6b48adabd29578eef rdf:first sg:person.01364457173.35
77 rdf:rest Nf913d3d999f74f808ea4453d5f489be1
78 N2a3f20dcbe1d43a8bb1649a148db84aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Metabolomics
80 rdf:type schema:DefinedTerm
81 N30fdade413324a869b07815d1f2562c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Time Factors
83 rdf:type schema:DefinedTerm
84 N3bca04edc4444ed596f5b9eefdbc87be schema:name readcube_id
85 schema:value a2dbcb4d24b622dcc693c9c546282df3afe57828e31f8ce393780f3a4f8f2e3a
86 rdf:type schema:PropertyValue
87 N3be5373611fb43889f1bcdf6f5c22c10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Young Adult
89 rdf:type schema:DefinedTerm
90 N3d54617f7d6c4040869eb59b4b60f14b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Magnetic Resonance Imaging
92 rdf:type schema:DefinedTerm
93 N3f51ffd08a6b4927930e8381b1a18553 rdf:first sg:person.01012741005.50
94 rdf:rest Nf192703ad3984d71ae6b19f25920234e
95 N4b33503c47d04aec8fe45758083fe38c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Huntington Disease
97 rdf:type schema:DefinedTerm
98 N521baf8edd204e9a8cc910423c4d8528 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Rilmenidine
100 rdf:type schema:DefinedTerm
101 N5ca1d67570b7481994318823696bffb5 rdf:first Ne4c0b3abf6c140cbb7842d8bd9c207eb
102 rdf:rest N6c31da74db1e47099be780365f7f3eaf
103 N5d3c8845ef964ae988ef4ed65157119d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Adrenergic alpha-Agonists
105 rdf:type schema:DefinedTerm
106 N60cc633d94a841c88e68760e302db458 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Retrospective Studies
108 rdf:type schema:DefinedTerm
109 N6c31da74db1e47099be780365f7f3eaf rdf:first sg:person.015072667762.55
110 rdf:rest Ncbd8593cae7e46b0a56667b107a72a18
111 N746fdca0896246cc9ee503c912c5f408 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Humans
113 rdf:type schema:DefinedTerm
114 N94c533a479674b43b194a0c3c8b513ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Longitudinal Studies
116 rdf:type schema:DefinedTerm
117 N9bb1b520c52b4d0b80c63ec5df543134 schema:name pubmed_id
118 schema:value 29075837
119 rdf:type schema:PropertyValue
120 N9f780e65f00246f285db8aa61642091b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Neuropsychological Tests
122 rdf:type schema:DefinedTerm
123 Na1262cecbd84433fba2a72ec849eee2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Middle Aged
125 rdf:type schema:DefinedTerm
126 Nb7db6290142041c282900a9f3e1feec6 rdf:first sg:person.0703455320.69
127 rdf:rest Nccffe0f409d34817abe5b2b4af8bca44
128 Ncbd8593cae7e46b0a56667b107a72a18 rdf:first sg:person.013473241432.70
129 rdf:rest N1a979c872b5c4bb6b48adabd29578eef
130 Nccffe0f409d34817abe5b2b4af8bca44 rdf:first sg:person.01143475656.63
131 rdf:rest Nf96b06ab6e56434b85a68c05ff8bd7ca
132 Nd2534afd58824cc68fd1c63e0daf95b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Female
134 rdf:type schema:DefinedTerm
135 Nd67644bbdf1b4f23b99994e2c3d372e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Adolescent
137 rdf:type schema:DefinedTerm
138 Ndf7fc0bc95974ca3b1acdd68860827bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Male
140 rdf:type schema:DefinedTerm
141 Ne109726208634d058327b0bdf06d271d schema:name nlm_unique_id
142 schema:value 0423161
143 rdf:type schema:PropertyValue
144 Ne1dc296fe12741d68cb9616b61aa491d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Brain
146 rdf:type schema:DefinedTerm
147 Ne42a84157f7c45608fd73a4357d338c1 schema:volumeNumber 264
148 rdf:type schema:PublicationVolume
149 Ne4c0b3abf6c140cbb7842d8bd9c207eb schema:affiliation https://www.grid.ac/institutes/grid.5335.0
150 schema:familyName Griffin
151 schema:givenName Jules
152 rdf:type schema:Person
153 Ne4dc59ffecaf4752af5b23bfb22f595d schema:name doi
154 schema:value 10.1007/s00415-017-8647-0
155 rdf:type schema:PropertyValue
156 Necbb611825194f9b9d6c5b3229117358 schema:issueNumber 12
157 rdf:type schema:PublicationIssue
158 Nf192703ad3984d71ae6b19f25920234e rdf:first sg:person.01244365253.48
159 rdf:rest Nb7db6290142041c282900a9f3e1feec6
160 Nf1aa928140f14cf3b9e30d0af136f1f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Oxazoles
162 rdf:type schema:DefinedTerm
163 Nf2e7e06300ea43998f10e2b5f5dc5669 schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Nf913d3d999f74f808ea4453d5f489be1 rdf:first sg:person.01104460675.05
166 rdf:rest rdf:nil
167 Nf96b06ab6e56434b85a68c05ff8bd7ca rdf:first sg:person.01256130314.05
168 rdf:rest N5ca1d67570b7481994318823696bffb5
169 Nfd2447810cea4ac1bca64111667b3bfc schema:name dimensions_id
170 schema:value pub.1092407062
171 rdf:type schema:PropertyValue
172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical and Health Sciences
174 rdf:type schema:DefinedTerm
175 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
176 schema:name Public Health and Health Services
177 rdf:type schema:DefinedTerm
178 sg:grant.2767200 http://pending.schema.org/fundedItem sg:pub.10.1007/s00415-017-8647-0
179 rdf:type schema:MonetaryGrant
180 sg:grant.2770378 http://pending.schema.org/fundedItem sg:pub.10.1007/s00415-017-8647-0
181 rdf:type schema:MonetaryGrant
182 sg:grant.2785012 http://pending.schema.org/fundedItem sg:pub.10.1007/s00415-017-8647-0
183 rdf:type schema:MonetaryGrant
184 sg:grant.3639485 http://pending.schema.org/fundedItem sg:pub.10.1007/s00415-017-8647-0
185 rdf:type schema:MonetaryGrant
186 sg:grant.3864363 http://pending.schema.org/fundedItem sg:pub.10.1007/s00415-017-8647-0
187 rdf:type schema:MonetaryGrant
188 sg:grant.4579569 http://pending.schema.org/fundedItem sg:pub.10.1007/s00415-017-8647-0
189 rdf:type schema:MonetaryGrant
190 sg:grant.6446046 http://pending.schema.org/fundedItem sg:pub.10.1007/s00415-017-8647-0
191 rdf:type schema:MonetaryGrant
192 sg:grant.7444390 http://pending.schema.org/fundedItem sg:pub.10.1007/s00415-017-8647-0
193 rdf:type schema:MonetaryGrant
194 sg:journal.1014525 schema:issn 0340-5354
195 1432-1459
196 schema:name Journal of Neurology
197 rdf:type schema:Periodical
198 sg:person.01012741005.50 schema:affiliation https://www.grid.ac/institutes/grid.415163.4
199 schema:familyName Underwood
200 schema:givenName Benjamin R.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012741005.50
202 rdf:type schema:Person
203 sg:person.01104460675.05 schema:affiliation https://www.grid.ac/institutes/grid.5335.0
204 schema:familyName Barker
205 schema:givenName Roger A.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104460675.05
207 rdf:type schema:Person
208 sg:person.01143475656.63 schema:affiliation https://www.grid.ac/institutes/grid.417815.e
209 schema:familyName Lazic
210 schema:givenName Stanley E.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143475656.63
212 rdf:type schema:Person
213 sg:person.01244365253.48 schema:affiliation https://www.grid.ac/institutes/grid.120073.7
214 schema:familyName Green-Thompson
215 schema:givenName Zeyn W.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244365253.48
217 rdf:type schema:Person
218 sg:person.01256130314.05 schema:affiliation https://www.grid.ac/institutes/grid.5335.0
219 schema:familyName Mason
220 schema:givenName Sarah L.
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256130314.05
222 rdf:type schema:Person
223 sg:person.013473241432.70 schema:affiliation https://www.grid.ac/institutes/grid.5335.0
224 schema:familyName Rowe
225 schema:givenName James B.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013473241432.70
227 rdf:type schema:Person
228 sg:person.01364457173.35 schema:affiliation https://www.grid.ac/institutes/grid.5335.0
229 schema:familyName Rubinsztein
230 schema:givenName David C.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364457173.35
232 rdf:type schema:Person
233 sg:person.015072667762.55 schema:affiliation https://www.grid.ac/institutes/grid.5335.0
234 schema:familyName Jones
235 schema:givenName P. Simon
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015072667762.55
237 rdf:type schema:Person
238 sg:person.0703455320.69 schema:affiliation https://www.grid.ac/institutes/grid.120073.7
239 schema:familyName Pugh
240 schema:givenName Peter J.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703455320.69
242 rdf:type schema:Person
243 sg:pub.10.1038/ng0893-398 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001162353
244 https://doi.org/10.1038/ng0893-398
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1001/jamaneurol.2013.123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030048782
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1001/jamaneurol.2013.4408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029048086
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/0895-4356(94)90122-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012537768
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/j.mam.2006.08.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005417342
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/s1474-4422(10)70276-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020920913
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/s1474-4422(11)70263-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041510619
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1016/s1474-4422(13)70088-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046613225
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1074/jbc.r109.072181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038402062
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1093/brain/awl027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027277788
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1093/hmg/ddi458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016587798
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1093/hmg/ddq093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002040437
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1159/000106735 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015122589
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1212/wnl.0b013e3182020123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064355787
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1212/wnl.29.1.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064362593
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1212/wnl.54.2.452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064378293
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1371/journal.pone.0029522 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022528286
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1517/14656566.2016.1109630 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038137101
279 rdf:type schema:CreativeWork
280 https://www.grid.ac/institutes/grid.120073.7 schema:alternateName Addenbrooke's Hospital
281 schema:name Addenbrooke’s Hospital, Hills Road, CB21 2QQ, Cambridge, UK
282 rdf:type schema:Organization
283 https://www.grid.ac/institutes/grid.415163.4 schema:alternateName Fulbourn Hospital
284 schema:name Fulbourn Hospital, Fulbourn, CB21 5EF, Cambridge, UK
285 rdf:type schema:Organization
286 https://www.grid.ac/institutes/grid.417815.e schema:alternateName AstraZeneca (United Kingdom)
287 schema:name Quantitative Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca, CB4 0WG, Cambridge, UK
288 rdf:type schema:Organization
289 https://www.grid.ac/institutes/grid.5335.0 schema:alternateName University of Cambridge
290 schema:name Addenbrooke’s Hospital, Hills Road, CB21 2QQ, Cambridge, UK
291 Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Hills Road, CB2 0XY, Cambridge, UK
292 Department of Biochemistry, University of Cambridge, CB2 1GA, Cambridge, UK
293 Department of Clinical Neurosciences, and MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge Biomedical Campus, CB2 0SZ, Cambridge, UK
294 John Van Geest Centre for Brain Repair, Forvie Site, Robinson Way, CB2 0PY, Cambridge, UK
295 UK Dementia Research Institute, University of Cambridge, Hills Road, CB2 0XY, Cambridge, UK
296 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...